DSHP is Dead What CMSs Recent Decision Means for Medicaid Post Written by Jason Helgerson, Founder and CEO CMS recently announced that it will no longer allow states to use Designated State Health Programs (DSHP) as a source of state match in their 1115 Medicaid Waivers
[9] Using retatrutide outside of an approved, ethics-committee-reviewed clinical trial carries significant risks, as research-grade peptides are not subject to the same manufacturing standards, purity controls, or safety oversight as licensed medicines
Visit us in Katy or The Woodlands, TX Call us at 832-986-6824
Request Batch-Specific COAs A generic COA that doesn't reference a specific batch number is nearly worthless it could be months old and from a completely different production run
Ensuring that BPC 157 dosing is adjusted according to progress is essential
People with neurodegenerative concerns Research on the connection between sleep disruption and neurodegenerative disease is growing rapidly